Lifeward appointed Mark Grant as the company’s new president and CEO, effective June 2. Larry Jasinski, Lifeward’s outgoing CEO, will serve as co-CEO and in an advisory capacity until the end of June to assist with the transition, and thereafter on an as-needed basis through the end of 2025.
“Mark brings 30 years of combined experience in commercial leadership, channel development, and strategic solutions, and is the perfect choice to lead Lifeward in its next stage of growth,” said Joseph Turk, chairman of the board of directors.
From 2004 to 2023, Grant held various leadership roles at Medtronic, a global healthcare technology company, rising to the level of vice president for the Americas. His responsibilities and achievements included directing the development and execution of strategies to deliver annual revenue targets in the diabetic home care market, opening commercial markets by establishing access to new direct-payer constituencies, including the US Department of Veterans Affairs, optimizing revenue cycle operations, identifying and pursuing new business opportunities based on market trends and competitor research, and restructuring the business to meet changing operational demands.
Prior to joining Lifeward, Grant was president of Americas and chief commercial officer of IMRA Surgical, an ethical surgical training solutions company. He provided leadership in setting operational and commercial strategies, spearheaded the development of multichannel sales and marketing efforts to bolster commercialization efforts, and played an integral leadership role in raising capital and developing the company’s enterprise strategy.
Grant also had roles at Bristol Myers Squibb and FLA Orthopedics. He has a Bachelor of Science degree in industrial technology from East Carolina University.
“As CEO, I look forward to helping Lifeward leverage its many strengths to achieve balanced and sustainable growth as we establish a strong foundation for the future and work strategically toward profitability,” Grant said.
